Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Arzneimittel-Forschung|May 1, 1990
Biotransformation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1-H-dibenz[2,3:6,7]oxepin o [4,5-c]pyrrolidine maleate in ratsH M von dem Wildenberg, L P Delbressine, F M Kaspersen, et al.
Survey of Ophthalmology|July 23, 1999
Neuroprotection in relation to retinal ischemia and relevance to glaucomaN N Osborne, M Ugarte, M Chao, et al.
International Journal of Sports Medicine|April 1, 1992
Plasma lipid levels in active and sedentary premenopausal femalesA C Perry, M H Shaw, L Hsia, et al.
Experimental Eye Research|September 2, 1999
Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retinaN N Osborne, L DeSantis, J H Bae, et al.
Water Resources Research|July 21, 2022
Modeling Anthropogenic and Environmental Influences on Freshwater Harmful Algal Bloom Development Detected by MERIS Over the Central United StatesJ S Iiames, W B Salls, M H Mehaffey, et al.
Archives of Physical Medicine and Rehabilitation|August 1, 1997
Evaluation of a training program for persons with SCI paraplegia using the Parastep 1 ambulation system: part 3. Lack of effect on bone mineral densityB M Needham-Shropshire, J G Broton, K J Klose, et al.
General Pharmacology|March 24, 1998
Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonistN N Osborne, C Cazevieille, J P Wood, et al.
Eye (London, England)|October 12, 2000
5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studiesN N Osborne, J P Wood, J Melena, et al.
Prosthetics and Orthotics International|April 1, 1997
The effects of prosthesis mass on metabolic cost of ambulation in non-vascular trans-tibial amputeesR S Gailey, M S Nash, T A Atchley, et al.
Paraplegia|November 1, 1991
Reversal of adaptive left ventricular atrophy following electrically-stimulated exercise training in human tetraplegicsM S Nash, S Bilsker, A E Marcillo, et al.
Pageof 7